Specifically, the downregulation of NAT8L increases cytosolic aspartate levels to promote glucose flux into the PPP, thus boosting purine biosynthesis and ensuring HCC cell proliferation [85]. The gene discussed is ASPNAT; the disease is hepatocellular carcinoma.